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Are Patients with Thrombophilia and Previous Venous Thromboem-
bolism at Higher Risk for Arterial Thrombosis?
Linnemann B, Schindewolf M, Zgouras D, et al. Thrombosis Research
2008;121:743-750.
Conclusion: Inherited thrombophilias do not substantially increase
the risk of arterial thrombosis.
Summary: Inherited thrombophilias are well recognized to increase
the risk of venous thromboembolism. The relationship between inherited
thrombophilias and arterial thrombosis is more controversial. A large meta-
analysis found a weak relationship between common genetic thrombophilias
and arterial thrombotic events with calculated odds ratios of 1.2 for Factor V
Leiden mutation and 1.3 for prothrombin gene mutation. Neither of these
calculations was adjusted for clinical concomitant cardiovascular risk factors.
The authors sought to use data from 1,081 consecutive patients (649
females and 432 males, 16-93 years of age) who were registered in a venous
thromboembolism registry in Germany. Patients were screened for Factor V
Leiden and prothrombin G20210A mutation, anticardiolipin antibodies,
and activities of factor VIII, protein C, protein S, and antithrombin.
In this study cohort, 40 patients or 3.7% had a prior myocardial
infarction and 3.8% (n41) had suffered a stroke. Other arterial thrombotic
events were infrequent. Factor VIII levels were more often elevated in
myocardial infarction (MI) patients than in controls (44.4% v. 25.9%,
p0.044) but this relationship did not hold after adjusting for traditional
cardiovascular risk factors. There was also an observed higher rate of lupus
anticoagulant inmyocardial infarction patients with an adjusted odds ratio of
3.3 (95% CI 0.84-12.8, p0.090). No differences in other tested thrombo-
philias approached significance in patients with MI or stroke relative to
control patients without MI or stroke.
Comment: Vascular surgeons sometimes see patients they feel are
“hypercoagulable”. I am sure a very few of them actually are but most are
probably just the victim of a technically imperfect procedure. Nevertheless,
testing for hypercoagulable states is common in vascular surgical patients.
This paper tells us native artery events induced by recognized thrombo-
philias are rare. It does not tell us if thrombophilias contribute to failed
arterial reconstructions. My belief, however, is genetically based throm-
bophilias are a very infrequent cause of a failed arterial reconstruction.
Just as “abnormal anatomy” is often the indicator of a confused surgeon,
so is it also that post-operative “hypercoagulable states” are more likely
the result of surgical imperfections than genetic abnormalities of the
coagulation system.
Cognitive Changes in Retirement among Senior Surgeons (CCRASS):
Results from the CCRASS Study
Bieliauskas LA, Langenecker S, Graver C, et al. J Am College Surgery
2008;207:69-79.
Conclusion: Surgeons demonstrate age related declines in attention,
reaction time, visual learning andmemory but are above normative values for
age. Self perceived cognitive changes play a role in surgeon’s decisions to
retire but are not related to objective measures of cognitive change.
Summary: After 60 years of age, most surgeons reduce their operative
work load considerably but 17% continue to operate even after after 70 years
of age (Ann Surg 1994; 220:382-390). Cognitive efficacy decreases mark-
edly after 75 years of age and while, with age there is an accumulated wisdom
and verbal knowledge, there is still an overall decline in cognitive processing
efficiency. In this study, the author studied the logic behind surgeons’
decisions to retire with specific emphasis on the role of perceived or con-
firmed cognitive decline in the decision to retire.
The authors administered three subtests from the Cambridge Neuro-
psychological Test Automated Battery to 359 surgeons at the annual meet-
ing of the American College of Surgeons over a six year period. These tests
measured sustained attention, reaction time, visual learning and memory.
The surgeons were also administered a survey to assess subjective cognitive
changes and the status of their surgical practice and retirement decisions.
The study demonstrated expected age related cognitive declines in all
measures. Measured reaction time, however, was notably better than among
age appropriate controls. There was an age related decrease in volume of
patients (p0.001), decrease in complexity of cases (p0.0001), and a
decrease in mastery of new technologic developments (p0.03). Surgeons
who reported that they had not consumed any alcohol in the 24 hours prior
to testing had slower reaction times than those who had consumed more
than two (p0.001) andmore than six drinks (p0.003) in the same period.
There was a marked relationship between surgeon’s self-reported cognitive
change and actual and anticipated retirement status. However, there was no
relationship between subjective cognitive change and objective measure-
ments of cognitive decline.
Comment: A surgeon’s decision to retire may be based on reaching a
specific age, or actual or perceived decline in cognitive or technical ability. In
this study, only 18% of surgeons based their decision to retire on age alone.
A self-perceived decline in cognitive abilities was, however, strongly associ-
ated with retirement status but objective measurements of cognitive decline
did not correlate with self perceptions of cognitive decline. Surgeons in
many cases may be choosing to retire pre-maturely.
Contaminated Heparin Associated with Adverse Clinic Events and
Activation of the Contact System
Kishimoto TK, Viswanathan K, Ganguly T, et al. N Engl J Med 2008;358:
2457-67.
Conclusion: Recent deaths associated with contaminated heparin ap-
pear to be mediated by activation of the contact system by over-sulfated
chondroitin sulfate (OSCS).
Summary: Beginning in November 2007 some patients undergoing
dialysis were developing symptoms of hypotension, facial swelling, tachycar-
dia, uticaria, and nausea. This was initially linked to heparin sodium for
injection (1000 units per ml, in 10 ml and 30 ml multi-dose vials) manufac-
tured by Baxter Healthcare. Initial recall of heparin sodium occurred on
January 17, 2008 and by April 13, 2008 there were 81 reports of death with
at least one sign or symptom of allergic reaction in patients receiving heparin
since January 1, 2007. On March 6, 2008 a similar cluster of events was
announced in Germany associated with heparin provided by a different
manufacturer. Subsequently, upon recommendations from the FDA, hepa-
rin was screened for contamination and widespread contamination of the
heparin supply in at least 12 countries was discovered. This contaminate was
identified as an unusual over-sulfated form of chondroitin sulfate (OSCS).
No other contaminates were observed. In this paper, the author sought to
establish a biologic link between OSCS and allergic type clinical manifesta-
tions occurring in patients receiving heparin.
The authors procured heparin from the FDA. This consisted of lots of
heparin associated with the clinical events reported as well as control lots.
The suspected and control lots were then screened in a blinded fashion for
presence of OSCS and for any biologic activity that could potentially link
OSCS to the observed clinical events. Activation of the complement cascade
and the contact system was investigated with in vitro assays. A swine model
was also used to test the ability of OSCS to duplicate the clinical manifesta-
tions associated with the adverse allergic type reactions to the contaminated
heparin lots.
In the contaminated lots of heparin, OSCS was found to directly
activate the kinin-kallikrein pathway. Activation of this pathway can lead to
generation of bradykinin, a potent vasoactive mediator. Generation of C3a
and C5a was also induced by OSCS. These are potent anaphylatoxins
derived from complement proteins. Plasma samples screened from various
species indicated that swine and humans were sensitive to the effects of
OSCS in a similar fashion. The authors then determined that OSCS con-
taining heparin and synthetically derived OSCS both induced hypotension
associated with kallikrein activity when administered intravenously in the pig
model.
Comment: The author’s results provide scientific rationale for a bio-
logic link between OSCS in contaminated lots of heparin and observed
clinical adverse events. This is elegant work and essentially a modern appli-
cation of Koch’s postulate. In the future, the heparin supply will need to be
screened for OSCS and other highly sulfated polysachride contaminates that
may activate the contact system and lead to serious adverse events.
Cost-Effectiveness of Endarterectomy in Patients with Asymptomatic
Carotid Artery Stenosis
Henriksson M, Lundgren F, Carlsson P. Brit J Surg 2008;95:715-720.
Conclusion: In patients with asymptomatic carotid stenosis, carotid
endarterectomy, in addition to best medical management, is cost effective in
men age 73 years or less. It is unlikely to be cost effective in older men or in
women.
Summary: Major randomized trials of carotid endarterectomy (CEA)
in addition to best medical management compared to best medical manage-
ment alone have indicated CEA is effective in reducing strokes in the patient
populations studied. The cost effectiveness of such a strategy in asymptom-
atic patients has not been well studied. In this study, the authors investigated
the cost effectiveness of CEA for asymptomatic patients in comparison to a
769
